Abstract
The objective of this study was to elucidate colonic mucosal ultrastructural effects of trinitrobenzene-sulphonic acid (TNBS) with and without co-administration of recombinant human interleukin-11 (rhIL-11). Using a standard colitis model (ir alcoholic TNBS), rats were sacrificed at 3~14 days after TNBS. Co-administration of rhIL-11 (100, 300 or 1000 μg/kg sc) was given for protection, and controls received saline or alcohol ir, or rhIL-11 sc alone. Transmission electron microscopy revealed that early TNBS-induced cytopathology was primarily in absorptive cells, changes which occurred prior to goblet cell damage. Progressive cellular changes included vacuolization and increased multivesicular bodies in cell apices, disconfiguration of microvilli, enlarged Golgi apparatuses, enlargement of basal inter-cellular spaces, and eventual desquamation of epithelium and apical bursting.
Organelle damage preceded surface changes and resembled ultrastructural changes reported for human ulcerative colitis. The principal effect of rhIL-11 was apparent massive release of mucus from goblet cells, filling the colonic crypts, and suggesting a mode of its protection.
Similar content being viewed by others
References
MacPherson B, Pfeiffer CJ. Experimental colitis. Digestion. 1976;14:424–52.
Beeken WL. Experimental inflammatory bowel disease. In: Krisner JB, Shorter RG, eds. Inflammatory Bowel Disease. Philadelphia: Lea and Febiger; 1988:37–49.
Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology. 1995;109:1344–67.
Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96:795–803.
Rampton DS. Colitis and nonsteroidal anti-inflammatory drugs. In: Domschke W, Dammann HG, eds. Prostaglandins and Leukotrienes in Gastrointestinal Diseases, Berlin: Springer-Verlag; 1988:254–9.
Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacano JD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology. 1989;97:326–37.
Zeitlin IJ, Smith AN. Mobilization of tissue kallikreins in inflammatory diseases of the colon. Gut. 1973;14:133–8.
Ekakim R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Gastroenterology. 1988;95:1167–72.
Kishimoto S, Kobayashi H, Shimizu S et al. Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis. Dig Dis Sci. 1992;37:1729–37.
Keshavarzian A, Sedghi S, Kanofsky J et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology. 1992;103:177–85.
Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut. 1990;31:686–9.
Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the pro-inflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology. 1992;103:65–71.
Mahida YR, Wu K, Patel S, Jewell DP. Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. Clin Exp Immunol. 1988;74:382–6.
Gross V, Andus T, Caesar I, Roth M, Schölmerich J. Evidence for continuous stimulation of interleukin 6 production in Crohn's disease. Gastroenterology. 1992;102:514–9.
Cominelli F, Nast CC, Llerena R, Dinarello CA, Zipser RD. Interleukin 1 suppresses inflammation in rabbit colitis. J Clin Invest. 1990;85:582–6.
Paul SR, Bennett F, Calvetti JA et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl Acad Sci USA. 1990;87:7512–6.
Mckinley D, Wu Q, Yang-Feng T, Yang YC. Genomic sequence and chromosomal location of human interleukin (IL)-11 gene. Genomics. 1992;13:814–19.
Du XX, Doerschuk CM, Orazi A, Williams DA. A bone-marrow-stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood. 1994;83:33–7.
Keith JC Jr, Albert L, Sonis ST, Pfeiffer CJ, Schaub RG. IL-11 a pleiotropic cytokine: Exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells. 1994;12(Suppl. 1):79–90.
Qiu BS, Pfeiffer CJ, Keith JC Jr. Protection by recombinant human interleukin-11 against experimental TNBS-induced colitis in rats. Dig Dis Sci. 1996;41:1625–30.
Pfeiffer CJ, Pfeiffer DC, Szabo S. Early ultrastructural changes in rat duodenal mucosa associated with cysteamine-induced ulcer. Exp Mol Pathol. 1987;46:102–13.
Pfeiffer CJ, Harding RK, Morris GP. Ultrastructural aspects of salicylate-induced damage to the gastric mucosa. In: Pfeiffer CJ, ed. Drugs and Peptic Ulcer, Vol. II. Boca Raton CRC Press; 1982:109–26.
Pfeiffer CJ, Dabareiner RM. Ultrastructure of Brunner's glands in the horse. J Submicrosc Cytol Pathol. 1992;24:581–8.
Pfeiffer CJ, Rowden G, Weibel J. Gastrointestinal Ultrastructure: An Atlas of Scanning and Transmission Electron Microscopy. Stuttgart: G. Thieme, Publishers; 1974:265–83.
Florey HW. Electron microscopic observations on goblet cells of the rat's colon. Q J Exp Physiol. 1960;85:153–76.
Ono K. Ultrastructure of the surface principal cells of the large intestine in postnatal developing rats. Anat Embryol. 1976;149:155–71.
Reeve DRE. An electron microscopic study of chronic ulcers of the colon in rats. Br J Exp Pathol. 1977;58:63–77.
Evangelista S, Meli A. Influence of capsaicin-sensitive fibres on experimentally-induced colitis in rats. J Pharm Pharmacol. 1989:41:574–5.
Donnellan WL. Early histological changes in ulcerative colitis, a light and electron microscopic study. Gastroenterology. 1966;50:519–40.
Nagle GJ, Kurtz SM. Electron microscopy of the human rectal mucosa. A comparison of idiopathic ulcerative colitis with inflammation of known etiologies. Am J Dig Dis. 1967;12:541–67.
Pfeiffer CJ, Qiu BS. Effects of chronic nitric oxide synthase inhibition on TNBS-induced colitis in rats. J Pharm Pharmacol. 1995;47:827–32.
Phillips TE, Wilson J. Morphometric analysis of mucous granule depletion and replenishment in rat colon. Dig Dis Sci. 1993;38:2299–304.
Tatsuta M, Yamamoto R, Iishi H, Nakaizumi A. Scanning electron microscopic observations on gastric mucus secretion in rats, and the effects of tetraprenylacetone. Digestion. 1995;56:175–80.
Bulbena O, Escolar G, Navarro C, Bravo L, Pfeiffer CJ. Gastroprotective effect of zinc acexamate against damage induced by nonsteroidal anti-inflammatory drugs. A morphological study. Dig Dis Sci. 1993;38:730–9.
Pfeiffer CJ. Experimental analysis of hydrogen ion diffusion in gastrointestinal mucus glycoprotein. Am J Physiol. 1981;240:G176–82.
Gross V, Andus T, Leser HG, Roth M, Scholmerich J. Inflammatory mediators in chronic inflammatory bowel diseases. Klin Wochenschr. 1991;69:981–7.
Kusugami K, Fukatsu A, Tanimoto M et al. Elevation of interleukin-6 in inflammatory bowel disease is macrophage and epithelial cell dependent. Dig Dis Sci. 199540:949–59.
Choi PM, Targan SR. Immunomodulator therapy in inflammatory bowel disease. Dig Dis Sci. 1994;39:1885–92.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pfeiffer, C.J., Sato, S., Qiu, B.S. et al. Cellular pathology of experimental colitis induced by trinitrobenzenesulphonic acid (TNBS): Protective effects of recombinant human interleukin-11. Inflammopharmacol 5, 363–381 (1997). https://doi.org/10.1007/s10787-997-0033-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10787-997-0033-6